TY - JOUR
T1 - Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men
AU - Halkitis, Perry N.
AU - Parsons, J. T.
AU - Wolitski, R. J.
AU - Remien, R. H.
N1 - Funding Information:
The Seropositive Urban Men’s Study (SUMS) was a cooperative agreement funded by the Centers for Disease Control and Prevention (CDC Grant ##U62/CCU213605). The following colleagues fully participated with the authors in the development, design, and implementation of SUMS: David Purcell, James Carey, Ann O’Leary (CDC); Cynthia Gomez, Robert Hays, Colleen Hoff (University of California-San Francisco), Michael Stirratt (Columbia University). We also acknowledge the many other SUMS project staff, particularly David Bimbi and Thomas Borkowski from the New York City site, who helped on various aspects of SUMS, and Ron Stall and Seth Kalichman for their editorial insights.
Funding Information:
Data for this investigation were collected as part of the Seropositive Urban Men’s Study (SUMS), a formative study of the sexual behaviours of HIV-positive MSM from two urban HIV epicentres (New York City and San Francisco). The project was funded by the Centers for Disease Control and Prevention (CDC). The data were collected from two cross-sectional samples developed through a targeted sampling strategy. All research activities were reviewed and approved by IRB at the participating institutions and CDC prior to implementation.
PY - 2003/2
Y1 - 2003/2
N2 - Data regarding HIV antiretroviral treatment regimens, access to treatment and medical care, and adherence to medications were collected as part of the Seropositive Urban Men's Study, a formative study of HIV-positive men who have sex with men. Participants (N = 456) were recruited from AIDS service organizations, mainstream gay venues and public/commercial sex environments. The sample was 94% gay or bisexually-identified; 29% were African American, 24% Latino and 30% white. The majority (71%) indicated being on antiretroviral treatment, and most were taking a protease inhibitor/nucleoside reverse transcriptase inhibitor combination. African American men in New York City were less likely to be on treatment. Among those on treatment (n = 322), 51% reported at least one day in which they had missed a dose of their medication and the mean number of days in which a dose was missed (in the past 30 days) was 1.72. Multivariate analyses indicated that avoidant coping, frequency of drinking alcohol and difficulty in communicating with sex partners about HIV were related to days of missed doses, suggesting the need or desire to escape from the reality of life with HIV as a potential explanation for poor adherence.
AB - Data regarding HIV antiretroviral treatment regimens, access to treatment and medical care, and adherence to medications were collected as part of the Seropositive Urban Men's Study, a formative study of HIV-positive men who have sex with men. Participants (N = 456) were recruited from AIDS service organizations, mainstream gay venues and public/commercial sex environments. The sample was 94% gay or bisexually-identified; 29% were African American, 24% Latino and 30% white. The majority (71%) indicated being on antiretroviral treatment, and most were taking a protease inhibitor/nucleoside reverse transcriptase inhibitor combination. African American men in New York City were less likely to be on treatment. Among those on treatment (n = 322), 51% reported at least one day in which they had missed a dose of their medication and the mean number of days in which a dose was missed (in the past 30 days) was 1.72. Multivariate analyses indicated that avoidant coping, frequency of drinking alcohol and difficulty in communicating with sex partners about HIV were related to days of missed doses, suggesting the need or desire to escape from the reality of life with HIV as a potential explanation for poor adherence.
UR - http://www.scopus.com/inward/record.url?scp=0037307960&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037307960&partnerID=8YFLogxK
U2 - 10.1080/095401221000039798
DO - 10.1080/095401221000039798
M3 - Article
C2 - 12655837
AN - SCOPUS:0037307960
SN - 0954-0121
VL - 15
SP - 89
EP - 102
JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
IS - 1
ER -